As of 2026-03-15, the EV/EBITDA ratio of Inari Medical Inc (NARI) is -138.50. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NARI's latest enterprise value is 4,641.90 mil USD. NARI's TTM EBITDA according to its financial statements is -33.52 mil USD. Dividing these 2 quantities gives us the above NARI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.8x - 14.0x | 11.2x |
| Forward P/E multiples | 14.0x - 16.8x | 14.4x |
| Fair Price | (7.30) - (7.33) | (6.61) |
| Upside | -109.1% - -109.2% | -108.3% |
| Date | EV/EBITDA |